Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques
Thomas A. Waldmann(Cancer Institute (WIA)), Stephen P. Creekmore(Bryan College), H. Clifford Lane(National Institute of Allergy and Infectious Diseases), David E. Kleiner(National Institutes of Health), Michael C. Sneller(National Institutes of Health), Bonita R. Bryant(Bryan College), Jason L. Yovandich(Bryan College), Liyanage P. Perera(Bryan College), Enrico Lugli(Humanitas University), J. M. Pletcher(Charles River Laboratories (United States)), William D. Figg(National Cancer Institute), Jeremy Smedley(Oregon National Primate Research Center), Mario Roederer(National Institutes of Health), Thomas A. Fleisher(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Carolyn K. Goldman(Bryan College), Roger Kurlander(National Institutes of Health Clinical Center), Jean M. Decker(Bryan College), Rhonda MacAllister(Science Applications International Corporation (United States))
Cited by 194
Related Papers
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
|New England Journal of Medicine|2010|3.3k
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
|The Lancet|2014|2.2k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k